MIMEDX GROUP INC - COMMON STOCK

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

31 Jul 2024 15:02:00 By Nasdaq GlobeNewswire

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

31 Jul 2024 15:01:00 By Nasdaq GlobeNewswire

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

22 Jul 2024 07:10:48 By Nasdaq GlobeNewswire

MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31

17 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

26 Jun 2024 15:01:00 By Nasdaq GlobeNewswire

MIMEDX to Participate in Upcoming Investor Conferences

15 May 2024 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces First Quarter 2024 Operating and Financial Results

30 Apr 2024 15:01:00 By Nasdaq GlobeNewswire

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

16 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA

27 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

20 Mar 2024 06:00:00 By Nasdaq GlobeNewswire

MIMEDX Introduces E-Commerce and Account Management Platform

13 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Announces Appointment of Two New Independent Directors

04 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

28 Feb 2024 15:01:00 By Nasdaq GlobeNewswire

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

20 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

12 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

22 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

29 Dec 2023 16:00:00 By Nasdaq GlobeNewswire

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

28 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

MIMEDX to Participate in Upcoming Investor Conferences

13 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

MIMEDX to Highlight Published Data at SAWC Fall

02 Nov 2023 07:00:01 By Nasdaq GlobeNewswire